Trial to Investigate GZ21T in Healthy Volunteers

PHASE1RecruitingINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

August 19, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Actinic Keratosis
Interventions
DRUG

GZ21T

GZ21T cream is intended to be studied as a potential treatment for patients with actinic keratoses and other dermatologic conditions which may be amendable to the study treatment.

Trial Locations (1)

75237

RECRUITING

CTC (Clinical Trial Consultants) AB, Uppsala

All Listed Sponsors
collaborator

CTC Clinical Trial Consultants AB

INDUSTRY

lead

Genzada Pharmaceuticals USA, Inc.

INDUSTRY